ArticleJournal of translational medicine2026

Salivary microbial signature highlighting actinomyces as a predictor of immune-checkpoint inhibitor monotherapy response in advanced non-small cell lung cancer.

Silvia Cavaliere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.